Screening for prostate cancer

International Urology and Nephrology

Volumn 33, Issue 2, 2001, Pages 249-257

  Gambert, Steven R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Prostate cancer; PSA; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER SCREENING; CLINICAL PRACTICE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; HUMAN; LABORATORY DIAGNOSIS; MALE; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATECTOMY; REVIEW; TRANSRECTAL ULTRASONOGRAPHY; AGED; ECHOGRAPHY; MASS SCREENING; METHODOLOGY; PHYSICAL EXAMINATION; PROSTATE; PROSTATE TUMOR;

AGED; HUMAN; MALE; MASS SCREENING; PHYSICAL EXAMINATION; PHYSICIAN'S PRACTICE PATTERNS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; HUMANS;

EID: 0035527533     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015290429403     Document Type: Review

References (21)

1. Prostate cancer awareness week: Results of screening
2. Screening for prostatic cancer with high-resolution ultrasound
3. Early detection of prostate cancer. Part 11: Estimating the risks, benefits, and costs
4. Prostate cancer screening and beliefs about treatment efficacy: A national survey of primary care physicians and urologists
5. Screening for prostate cancer: What do general practitioners think?
6. Prostate cancer screening in primary care
7. Early detection of prostate cancer. Part 1: Prior probability and effectiveness of tests
8. Overdiagnosis of prostate carcinoma by screening: An estimate based on the results of the Florence Screening Pilot Study
9. An analysis of digital rectal examination and serum-prostate-specific antigen in the early detection of prostate cancer in general practice
10. The European Randomized Study of Screening for Prostate Cancer: An update
11. Screening for prostatic carcinoma with prostate specific antigen
12. Prostate cancer facts and fiction
13. Screening digital rectal examination and prostate cancer mortality: A population-based case-control study
14. Screening decreases prostate cancer death: First analysis of the 1988 Quebec prospective randomized controlled trial
15. Relationship of prostate-specific antigen levels to prostate volume and age in mass screening subjects
16. Prostate-specific antigen (PSA), PSA density and age-adjusted PSA reference values in screening for prostate cancer: A study of a randomly selected population of 2,400 men
17. Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific range as a cutoff for abnormal values
18. The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population
19. Prostate cancer detection - In men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examinations. Enhancement of specificity with free PSA
20. The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percentage of free serum prostate specific antigen levels in men without clinically detectable prostate cancer
21. Improvement of specificity in PSA-based screening by using PSA-transition zone density and percent free PSA in addition to total PSA levels